Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Go back to Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 16.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.11 | 52 Week High | $0.19 | |||
| Open | $16.11 | 52 Week Low | $0.07 | |||
| Day High | $16.11 | P/E | N/A | |||
| Day Low | $16.11 | EPS | $-0.01 | |||
| Volume | 137 | |||||
| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 16.11 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.11 | 52 Week High | $0.19 | |||
| Open | $16.11 | 52 Week Low | $0.07 | |||
| Day High | $16.11 | P/E | N/A | |||
| Day Low | $16.11 | EPS | $-0.01 | |||
| Volume | 137 | |||||

